BGT226
BGT226 (NVP-BGT226) is a potent dual inhibitor of PI3K and mTOR, demonstrating high potency against PI3Kα, β, and γ isoforms. It is utilized in preclinical research to investigate oncogenic signaling pathways and has been studied in various cancer cell lines and in vivo tumor models.
Product Specifications
CAS Number
915020-55-2
Product Name Alternative
PI3K, PI3Kγ, PI3Kβ, PI3Kα, Autophagy, BGT 226, BGT226, BGT-226, BGT226 free base, mTOR, NVP-BGT 226, NVP-BGT226, NVP-BGT-226, Mammalian target of Rapamycin
Field of Research
Cell Biology, Signal Transduction
Purity
95.74% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:1 mg/mL (1.87 mM) ; DMSO:65 mg/mL (121.6 mM)
Smiles
COc1ccc (cn1) -c1ccc2ncc3n (C) c (=O) n (-c4ccc (N5CCNCC5) c (c4) C (F) (F) F) c3c2c1
Molecular Formula
C28H25F3N6O2
Molecular Weight
534.53
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog